Emanuela Sant’Antonio
IRCCS Ospedale San Raffaele(IT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Kruppel-like factors research
Most-Cited Works
- → Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms(2013)1,952 cited
- → JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes(2013)576 cited
- → Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis(2014)381 cited
- → Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms(2015)280 cited
- → Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group(2016)93 cited
- → Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms(2013)92 cited
- → High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists(2016)89 cited
- → RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features(2020)77 cited
- → CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis(2014)71 cited
- → Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases(2019)68 cited